Annual Report 2025

NOTESTOTHE CONSOLIDATED FINANCIAL STATEMENTS For the year ended 31 December 2025 112 The United Laboratories International Holdings Limited Annual Report 2025 22. INVENTORIES 2025 2024 RMB’000 RMB’000 Raw materials 740,103 723,914 Work in progress 329,393 290,269 Finished goods 1,299,637 1,419,983 2,369,133 2,434,166 23. TRADE AND BILLS RECEIVABLES, OTHER RECEIVABLES, DEPOSITS AND PREPAYMENTS 2025 2024 RMB’000 RMB’000 Trade receivables from contracts with customers 2,248,570 2,406,076 Less: allowance for credit losses (31,812) (13,166) Banker’s acceptance bills receivables 1,982,202 3,333,266 Less: allowance for credit losses (174) (212) Consideration receivables (Note 10) 339,574 339,574 Less: allowance for credit losses (339,574) (339,574) Value added tax receivables 268,396 235,963 Other receivables, deposits and prepayments 287,707 321,947 Less: allowance for credit losses (13,171) (11,551) 4,741,718 6,272,323 At 1 January 2024, gross carrying amount of trade receivables from contracts with customers amounted to RMB2,378,638,000. The Group normally allows a credit period ranging from 45 days to 180 days (2024: 45 days to 180 days) to its trade customers, and may be extended to selected customers subject to their trade volume and historical settlement records with the Group. The banker’s acceptance bills receivables have a general maturity period of between 90 days and 1 year (2024: 90 days to 1 year).